REPORTS

Let’s Pullulate and Expand Your Business

Spine Biologics Market - Global Professional Analysis and Forecast to 2026

Oct 18, 2019  |  182 PAGES  |  REPORT CODE: CMM216455
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Spine Biologics market was valued at 2200 Million US$ in 2018 and is projected to reach 3255 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.02% during the forecast period.

This report presents the market size and development trends by detailing the Spine Biologics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Spine Biologics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Spine Biologics industry and will help you to build a panoramic view of the industrial development.

Spine Biologics Market, By Type:

  • Platelet Rich Plasma (PRP)

  • Bone Graft Substitute

  • Bone Graft

Spine Biologics Market, By Application:

  • Posterior Lumbar Interbody Fusion

  • Anterior Cervical Discectomy and Fusion

  • Others

Some of the leading players are as follows:

  • Zimmer Biomet

  • Depuy Synthes

  • Medtronic

  • Stryker Corporation

  • Globus Medical

  • Wright Medical Technology

  • Nuvasive

  • Orthofix International

  • Exactech

  • Nutech

  • X-Spine

  • Arthrex

  • Alphatec spine

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Spine Biologics Market: Technology Type Analysis

  • 4.1 Spine Biologics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Spine Biologics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Platelet Rich Plasma (PRP)

    • 4.3.2 Bone Graft Substitute

    • 4.3.3 Bone Graft

5 Spine Biologics Market: Product Analysis

  • 5.1 Spine Biologics Product Market Share Analysis, 2018 & 2026

  • 5.2 Spine Biologics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Spine Biologics Market: Application Analysis

  • 6.1 Spine Biologics Application Market Share Analysis, 2018 & 2026

  • 6.2 Spine Biologics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Posterior Lumbar Interbody Fusion

    • 6.3.2 Anterior Cervical Discectomy and Fusion

    • 6.3.3 Others

7 Spine Biologics Market: Regional Analysis

  • 7.1 Spine Biologics Regional Market Share Analysis, 2018 & 2026

  • 7.2 Spine Biologics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Zimmer Biomet

    • 9.1.1 Zimmer Biomet Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Depuy Synthes

    • 9.2.1 Depuy Synthes Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Medtronic

    • 9.3.1 Medtronic Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Stryker Corporation

    • 9.4.1 Stryker Corporation Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Globus Medical

    • 9.5.1 Globus Medical Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Wright Medical Technology

    • 9.6.1 Wright Medical Technology Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Nuvasive

    • 9.7.1 Nuvasive Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Orthofix International

    • 9.8.1 Orthofix International Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Exactech

    • 9.9.1 Exactech Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Nutech

    • 9.10.1 Nutech Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 X-Spine

    • 9.11.1 X-Spine Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Arthrex

    • 9.12.1 Arthrex Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Alphatec spine

    • 9.13.1 Alphatec spine Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

 

The List of Tables and Figures (Totals 74 Figures and 136 Tables)

  • Figure Platelet Rich Plasma (PRP) Spine Biologics market, 2015 - 2026 (USD Million)

  • Figure Bone Graft Substitute Spine Biologics market, 2015 - 2026 (USD Million)

  • Figure Bone Graft Spine Biologics market, 2015 - 2026 (USD Million)

  • Figure Posterior Lumbar Interbody Fusion market, 2015 - 2026 (USD Million)

  • Figure Anterior Cervical Discectomy and Fusion market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Spine Biologics market, by country, 2015 - 2026 (USD Million)

  • Table North America Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table North America Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table North America Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Canada Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Canada Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Europe Spine Biologics market, by country, 2015 - 2026 (USD Million)

  • Table Europe Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Europe Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Europe Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Germany Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Germany Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table France Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table France Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Italy Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Italy Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Spain Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Spain Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Spine Biologics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table China Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table China Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Japan Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Japan Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table India Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table India Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Spine Biologics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table MEA Spine Biologics market, by country, 2015 - 2026 (USD Million)

  • Table MEA Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table MEA Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table MEA Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Spine Biologics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Spine Biologics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Spine Biologics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Zimmer Biomet Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Depuy Synthes Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medtronic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Stryker Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Globus Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Wright Medical Technology Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nuvasive Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Orthofix International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Exactech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nutech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table X-Spine Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Arthrex Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alphatec spine Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top